C
The startup develops immunotherapies that activate the immune system to identify and attack cancer cells by targeting the tumor microenvironment. This approach enhances both innate and adaptive immune responses, providing healthcare professionals with a method to improve cancer treatment outcomes.
Canton, United States
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops immunotherapies that activate the immune system to identify and attack cancer cells by targeting the tumor microenvironment. This approach enhances both innate and adaptive immune responses, providing healthcare professionals with a method to improve cancer treatment outcomes.